• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Incannex Healthcare Inc. - Common Stock (NQ: IXHL )

    2.220 UNCHANGED
    Streaming Delayed Price Updated: 3:59 PM EDT, Jul 23, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 2.220
    Bid (Size) 2.100 (8)
    Ask (Size) 2.500 (9)
    Prev. Close 2.220
    Today's Range 2.220 - 2.220
    52wk Range 0.8000 - 12.68
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
    We have the biggest pre-market stock movers that investors are going to want to start the trading week with on Monday morning! 
    Via InvestorPlace
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
    Pre-market stock movers are worth checking out on Thursday as we dig into all of the biggest news moving shares this morning! 
    Via InvestorPlace

    Performance

    YTD
    -49.55%
    -49.55%
    1 Month
    -34.32%
    -34.32%
    3 Month
    -2.63%
    -2.63%
    6 Month
    -44.91%
    -44.91%
    1 Year
    +16.84%
    +16.84%

    More News

    Read More
    FDA Experts Weigh In On Incannex's CannQuit-O With Feedback On CBD As Treatment For Opioid Use Disorder
    Via Benzinga
    Exposures Product Safety
    Stonegate Healthcare Partners Releases Report on Potentially Transformative Therapies for Generalized Anxiety Disorder (GAD)
    Via Newsfile
    Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More
    Via Benzinga
    Largest Psychedelic Drug Stocks Up Another 10% Last Week; Now Up 54% YTD
    Via Talk Markets
    March Recap: Largest Psychedelic Drug Stocks Up Another 5%
    Via Talk Markets
    Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta's Influence
    Via Benzinga
    Psychedelic-Assisted Therapy Advancements Create A New Horizon For Mental Health In Colorado
    Via Benzinga
    Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More
    Via Benzinga
    Topics Economy
    Exposures Interest Rates
    Psychedelic Compound-Based Drug Stock, Mind Medicine, Up 56% Last Week
    Via Talk Markets
    Exposures Product Safety
    Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More
    Via Benzinga
    Largest Psychedelic Compound-Based Drug Stocks Up 15% In February; Now Up 33% YTD
    Via Talk Markets
    Psilocybin-Assisted Therapy Achieves Positive Clinical Trial Results For Treating Generalized Anxiety
    Via Benzinga
    Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    What's Going On With Incannex Stock?
    Via Benzinga
    How I Swing Trade Via Strength With Recent Examples
    Via Talk Markets
    Psychedelic Stocks Index Popped 8% Last Week, Led By Incannex
    Via Talk Markets
    Psychedelics Headlines: Trauma-Informed Care, Valentine's Day & MDMA, Academics On Drugs And More
    Via Benzinga
    Psyched: Psychedelics & Sex, MDMA And Federal Approval, Canadians For End-Of-Life Care And More
    Via Benzinga
    5 Largest Psychedelic Compound-Based Drug Stocks Up 17% Last Week
    Via Talk Markets
    Psyched: Suggestibility And Psychedelics' Effects, EU's $7M Research Fund, Australia's Treatment Delivery, BZ Podcast And More
    Via Benzinga
    Podcast: International Cannabis And Psychedelics Co. Is Working 'Hand In Hand' With FDA To Forge New Therapy Frontiers
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis Product Safety
    5 Largest Psychedelic Drug Stocks Advanced Slightly Last Week
    Via Talk Markets
    Psyched: $100M For MDMA Therapy, VA Funds, 2024 Watchlist, Reform Updates And More
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.